Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV is a research paper published in Journal of Virus Eradication (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: UM1 AI068636
NIAID NIH HHS
Grant: UM1 AI069471
NIAID NIH HHS
Grant: UM1 AI069496
NIAID NIH HHS
Grant: UM1 AI106701
NIDA NIH HHS
Grant: K24 DA034621
NIAID NIH HHS
Grant: UM1 AI068634
National Institutes of Health
Grant: 5UM1AI068634-09
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
National Institutes of Health
Grant: 5K24DA034621-10
Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
National Institutes of Health
Grant: 3UM1AI068636-19SC
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
National Institutes of Health
Grant: 5UM1AI069496-09
San Francisco Bay Clinical Trials Unit
NIAID
National Institute on Drug Abuse
Fields of Study
Keywords